1. Home
  2. UPC vs MIRA Comparison

UPC vs MIRA Comparison

Compare UPC & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • MIRA
  • Stock Information
  • Founded
  • UPC 1998
  • MIRA 2020
  • Country
  • UPC China
  • MIRA United States
  • Employees
  • UPC N/A
  • MIRA N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPC Health Care
  • MIRA Health Care
  • Exchange
  • UPC Nasdaq
  • MIRA Nasdaq
  • Market Cap
  • UPC 6.2M
  • MIRA 17.1M
  • IPO Year
  • UPC 2021
  • MIRA 2023
  • Fundamental
  • Price
  • UPC $0.36
  • MIRA $1.05
  • Analyst Decision
  • UPC
  • MIRA Strong Buy
  • Analyst Count
  • UPC 0
  • MIRA 2
  • Target Price
  • UPC N/A
  • MIRA $14.00
  • AVG Volume (30 Days)
  • UPC 4.3M
  • MIRA 552.1K
  • Earning Date
  • UPC 01-01-0001
  • MIRA 11-11-2024
  • Dividend Yield
  • UPC N/A
  • MIRA N/A
  • EPS Growth
  • UPC N/A
  • MIRA N/A
  • EPS
  • UPC N/A
  • MIRA N/A
  • Revenue
  • UPC $26,725,919.00
  • MIRA N/A
  • Revenue This Year
  • UPC N/A
  • MIRA N/A
  • Revenue Next Year
  • UPC N/A
  • MIRA N/A
  • P/E Ratio
  • UPC N/A
  • MIRA N/A
  • Revenue Growth
  • UPC N/A
  • MIRA N/A
  • 52 Week Low
  • UPC $0.20
  • MIRA $0.51
  • 52 Week High
  • UPC $4.32
  • MIRA $6.40
  • Technical
  • Relative Strength Index (RSI)
  • UPC 30.58
  • MIRA 38.97
  • Support Level
  • UPC $0.31
  • MIRA $1.04
  • Resistance Level
  • UPC $1.00
  • MIRA $1.20
  • Average True Range (ATR)
  • UPC 0.09
  • MIRA 0.07
  • MACD
  • UPC 0.12
  • MIRA 0.02
  • Stochastic Oscillator
  • UPC 20.17
  • MIRA 19.44

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: